![Hong Ma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hong Ma
Hoofd Techniek/Wetenschap/O&O bij
CARSGEN THERAPEUTICS HOLDINGS LIMITED
Profiel
Hong Ma is currently a Member at the American Society of Hematology and a Senior Vice President-Clinical Development at CARsgen Therapeutics Holdings Ltd. In the past, he worked as a Director-Clinical Development at Bellicum Pharmaceuticals, Inc., Director-Clinical Operations at Endocyte, Inc., and Senior Medical Director at Immatics US, Inc. Dr. Ma holds an MBA degree from the University of Georgia, a graduate degree from Central South University, and an undergraduate degree from Central South University.
Actieve functies van Hong Ma
| Bedrijven | Functie | Begin |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 01-01-2016 |
Eerdere bekende functies van Hong Ma
| Bedrijven | Functie | Einde |
|---|---|---|
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2016 |
| ENDOCYTE, INC. | Corporate Officer/Principal | 01-07-2014 |
Opleiding van Hong Ma
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
77
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Central South University
 Central South University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
CARsgen Therapeutics Holdings Ltd.
 CARsgen Therapeutics Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
